SCHEMBL19743378

SCHEMBL19743378

SC(Cl)(Cc1ccccc1)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 4/20 0.50
CYP2C9 P11712 2/20 0.50
CYP2C19 P33261 2/20 0.50
TSHR P16473 1/20 0.44
CALM1 P0DP23 1/20 0.42
SLC6A2 P23975 1/20 0.41
TAAR1 Q96RJ0 1/20 0.41
KIF11 P52732 3/20 0.40
KCNA5 P22460 1/20 0.39
LMNA P02545 1/20 0.39
CYP2D6 P10635 1/20 0.39
IDO1 P14902 1/20 0.39
HIF1A Q16665 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
ATM Q13315 1/20 0.37
FDPS P14324 1/20 0.36
CYP19A1 P11511 1/20 0.36
CYP3A4 P08684 2/20 0.35
RECQL P46063 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28605759 0.76 CYP2C9 (0.54) CYP1A2CYP2C9CYP2C19CALM1SLC6A2
SCHEMBL9792024 0.76 CYP1A2 (0.54) CYP1A2CYP2C9CYP2C19TSHRCALM1
SCHEMBL4052885 0.76 CYP2C9 (0.54) CYP1A2CYP2C9CYP2C19CALM1SLC6A2
SCHEMBL8208882 0.76 CYP1A2 (0.54) CYP1A2CYP2C9CYP2C19TSHRCALM1
SCHEMBL2562928 0.74 TAAR1 (0.48) CYP1A2TSHRTAAR1KIF11
Phosphine SCHEMBL7910929 0.74 CYP1A2 (0.52) CYP1A2CYP2C9CYP2C19TSHRCALM1
SCHEMBL4186835 0.73 CYP1A2 (0.62) CYP1A2CYP2C9CYP2C19TSHRCALM1
SCHEMBL10936747 0.73 SLC6A2 (0.52) CYP1A2CYP2C9CYP2C19TSHRSLC6A2
SCHEMBL15225151 0.73 SLC6A2 (0.52) CYP1A2CYP2C9CYP2C19TSHRSLC6A2
SCHEMBL8586998 0.73 CYP2C9 (0.61) CYP1A2CYP2C9CYP2C19TSHRSLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3475282-A1 [1,2,3]TRIAZOLO[4,5-D]PYRIMIDINE DERIVATIVES WITH AFFINITY FOR THE TYPE-2 CANNABINOID RECEPTOR H. Hoffnabb-La Roche Ag (CH) 2019-05-01 EP disclosed
WO-2017220517-A1 [1,2,3]TRIAZOLO[4,5-D]PYRIMIDINE DERIVATIVES WITH AFFINITY FOR THE TYPE-2 CANNABINOID RECEPTOR F. HOFFMANN-LA ROCHE AG (CH) 2017-12-28 WO disclosed